NOVT

NOVT R&D Expenses

$94.18MTTM · USD

Period ending:

NOVT FY R&D ExpensesUSD
NOVT FY R&D Expenses1998-12-31: $13.00M1999-12-31: $28.70M2000-12-31: $33.93M2001-12-31: $25.63M2002-12-31: $20.44M2003-12-31: $13.90M2004-12-31: $23.98M2005-12-31: $25.67M2006-12-31: $30.64M2007-12-31: $30.49M2008-12-31: $45.59M2009-12-31: $28.25M2010-12-31: $29.86M2011-12-31: $31.97M2012-12-31: $22.39M2013-12-31: $26.35M2014-12-31: $28.95M2015-12-31: $31.04M2016-12-31: $32.00M2017-12-31: $41.67M2018-12-31: $51.02M2019-12-31: $55.97M2020-12-31: $61.00M2021-12-31: $72.52M2022-12-31: $85.77M2023-12-31: $91.68M2024-12-31: $95.52M2025-12-31: $95.48M$95.52M$0.00
1998-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NOVT r&d expenses history

Research and development spending. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.

Novanta Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
95,484,000
95,515,000
91,682,000
85,770,000
72,522,000
60,996,000
55,965,000
51,024,000
41,673,000
32,002,000
31,043,000
28,954,000
26,352,000
22,393,000
31,966,000
29,857,000
28,254,000
45,591,000
30,489,000
30,639,000
25,671,000
23,975,000
13,895,000
20,444,000
25,634,000
33,931,000
28,700,000
13,000,000

Compare r&d expenses

All NOVT financial metrics · NOVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.